Literature DB >> 18268245

Prevalence of SOD1 mutations in the Italian ALS population.

A Chiò1, B J Traynor, F Lombardo, M Fimognari, A Calvo, P Ghiglione, R Mutani, G Restagno.   

Abstract

BACKGROUND: Five to 10% of amyotrophic lateral sclerosis (ALS) cases are reported to be familial (FALS), and mutations of SOD1 account for 20% of these cases. However, estimates of SOD1 mutation prevalence have been exclusively based on case series and clinic referral cohorts.
OBJECTIVE: To assess the frequency and nature of SOD1 mutations in a large population-based cohort of Italian patients diagnosed with ALS over a 6-year period.
METHODS: All ALS cases incident in Piemonte and Valle d'Aosta, Italy, are collected through a prospective epidemiologic register. Almost all patients with ALS resident in the largest province of Piemonte (Turin) have been evaluated for SOD1 mutations in the 6-year period 2000 through 2005.
RESULTS: During the study period, 386 residents of Turin province were diagnosed with ALS (mean crude incidence rate of 2.9/100,000/year). Twenty-two patients (5.7%) had a positive family history of ALS. SOD1 analysis was performed in 325 patients (84.2% of the whole cohort), including all FALS cases. Five patients carried a SOD1 coding mutation, three with a family history of ALS (13.6% of FALS) and two in sporadic cases (0.7% of sporadic ALS).
CONCLUSIONS: In this population-based series, the frequency of familial amyotrophic lateral sclerosis (FALS) was lower than that reported in series from ALS referral centers. While the frequency of SOD1 mutations in FALS was similar to the data reported in the literature, only 0.7% of sporadic ALS cases had a SOD1 mutation. Our data indicate that studies from referral centers may overestimate the frequency of FALS and of SOD1 mutations in sporadic ALS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268245     DOI: 10.1212/01.wnl.0000299187.90432.3f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

Review 1.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 3.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

4.  Polymorphism of rs3737597 in DISC1 Gene on Chromosome 1q42.2 in sALS Patients: a Chinese Han Population Case-Control Study.

Authors:  Libin Deng; Liwei Huo; Jie Zhang; Xiaoli Tang; Zhujun Cheng; Gang Li; Xin Fang; Jinsong Xu; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

5.  Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.

Authors:  Adriano Chiò; Giuseppe Borghero; Gabriella Restagno; Gabriele Mora; Carsten Drepper; Bryan J Traynor; Michael Sendtner; Maura Brunetti; Irene Ossola; Andrea Calvo; Maura Pugliatti; Maria Alessandra Sotgiu; Maria Rita Murru; Maria Giovanna Marrosu; Francesco Marrosu; Kalliopi Marinou; Jessica Mandrioli; Patrizia Sola; Claudia Caponnetto; Gianluigi Mancardi; Paola Mandich; Vincenzo La Bella; Rossella Spataro; Amelia Conte; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Fabrizio Pisano; Ilaria Bartolomei; Fabrizio Salvi; Giuseppe Lauria Pinter; Isabella Simone; Giancarlo Logroscino; Antonio Gambardella; Aldo Quattrone; Christian Lunetta; Paolo Volanti; Marcella Zollino; Silvana Penco; Stefania Battistini; Alan E Renton; Elisa Majounie; Yevgeniya Abramzon; Francesca Luisa Conforti; Fabio Giannini; Massimo Corbo; Mario Sabatelli
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

Review 6.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

Review 7.  Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

8.  A de novo missense mutation of the FUS gene in a "true" sporadic ALS case.

Authors:  Adriano Chiò; Andrea Calvo; Cristina Moglia; Irene Ossola; Maura Brunetti; Luca Sbaiz; Shiao-lin Lai; Yevgeniya Abramzon; Bryan J Traynor; Gabriella Restagno
Journal:  Neurobiol Aging       Date:  2010-07-03       Impact factor: 4.673

Review 9.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

Review 10.  State of play in amyotrophic lateral sclerosis genetics.

Authors:  Alan E Renton; Adriano Chiò; Bryan J Traynor
Journal:  Nat Neurosci       Date:  2013-12-26       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.